| Khan, M.B.; Lu, J.; Arutyunova, E.; Young, H.S.; Lemieux, M.J. et al. (2021). Improved Feline Drugs as SARS-CoV-2 Mpro Inhibitors: Structure-Activity Studies & Micellar Solubilization for Enhanced Bioavailability. Protein Data Bank: 7ldl. |
CMCF-BM |
PDB Deposition |
Health |
| Lin, Chang Sheng-Huei (2021). Peptidoglycan binding by Pgp2 and Ape1 determines Campylobacter jejuni helical cell shape. Supervisor: Murphy, Michael E. P.. BC, Canada: University of British Columbia. http://hdl.handle.net/2429/79511. |
CMCF-BM, CMCF-ID |
Doctoral Thesis |
Agriculture |
| Mao, Z.W.; Xia, W.; Tao, X. (2021). The crystal structure of SARS-CoV-2 3CLpro with Zinc. Protein Data Bank: 7d64. |
CMCF-BM, CMCF-ID |
PDB Deposition |
Health |
| Pham, N.T.H.; Calmettes, C.; Doucet, N. (2021). Crystal structure of G16S human Galectin-7 mutant. Protein Data Bank: 6vtr. |
CMCF-BM |
PDB Deposition |
Health |
| Pham, N.T.H.; Calmettes, C.; Doucet, N. (2021). Crystal structure of G16C human Galectin-7 mutant. Protein Data Bank: 6vtp. |
CMCF-BM |
PDB Deposition |
Health |
| Pham, N.T.H.; Calmettes, C.; Doucet, N. (2021). Crystal structure of human Galectin-7 in complex with 4-O-beta-D-Galactopyranosyl-D-glucose. Protein Data Bank: 6vto. |
CMCF-BM |
PDB Deposition |
Health |
| Radka, C.D.; Aller, S.G. (2021). YfeA oligomer crystal 1, form 1. Protein Data Bank: 7me1. |
CMCF-BM |
PDB Deposition |
Health |
| Radka, Christopher D.; Aller, Stephen G. (2021). Site 2 of the Yersinia pestis substrate-binding protein YfeA is a dynamic surface metal-binding site. Acta Crystallographica Section F:Structural Biology Communications 77(9) , 286-293. 10.1107/s2053230x21008086. [PDB: 7me1] |
CMCF-BM |
Peer-Reviewed Article |
Health |
| Schoepfer, Valerie A.; Lum, Jullieta E.; Lindsay, Matthew B. J. (2021). Molybdenum(VI) Sequestration Mechanisms During Iron(II)-Induced Ferrihydrite Transformation. ACS Earth and Space Chemistry 5(8) , 2094-2104. 10.1021/acsearthspacechem.1c00152. |
BIOXAS-MAIN, CMCF-BM |
Peer-Reviewed Article |
Environment |
| Akaki, Tatsuo; Bessho, Yuki; Ito, Takashi; Fujioka, Shingo; Ubukata, Minoru et al. (2021). Fragment-based lead discovery to identify novel inhibitors that target the ATP binding site of pyruvate dehydrogenase kinases. Bioorganic and Medicinal Chemistry 44, 116283. 10.1016/j.bmc.2021.116283. [PDB: 7ebb] |
CMCF-ID |
Peer-Reviewed Article |
Health |
| Boniecki, M.T.; Cygler, M. (2021). Structure of the (NIAU)2 complex with N-terminal mutation of ISCU2 Y35D at 2.5 A resolution. Protein Data Bank: 7rtk. |
CMCF-ID |
PDB Deposition |
Health |
| Ereno-Orbea, J.; Sicard, T.; Julien, J.P. (2021). CD22 d6-d7 in complex with Fab m971. Protein Data Bank: 7o52. |
CMCF-ID |
PDB Deposition |
Health |
| Ereno-Orbea, J.; Sicard, T.; Julien, J.P. (2021). m971 Fab in complex with anti-Kappa VHH domain. Protein Data Bank: 7o4y. |
CMCF-ID |
PDB Deposition |
Health |
| Ereño-Orbea, June; Liu, Xianglei; Sicard, Taylor; Kucharska, Iga; Li, Wei et al. (2021). Structural details of monoclonal antibody m971 recognition of the membrane-proximal domain of CD22. Journal of Biological Chemistry 297(2) , 100966. 10.1016/j.jbc.2021.100966. [PDB: 7o4y, 7o52] |
CMCF-ID |
Peer-Reviewed Article |
Health |
| Gavai, Ashvinikumar V.; Norris, Derek; Delucca, George; Tortolani, David; Tokarski, John S. et al. (2021). Discovery and Preclinical Pharmacology of an Oral Bromodomain and Extra-Terminal (BET) Inhibitor Using Scaffold-Hopping and Structure-Guided Drug Design. Journal of Medicinal Chemistry 64(19) . 10.1021/acs.jmedchem.1c00625. [PDB: 5s9r] |
CMCF-ID |
Peer-Reviewed Article |
Health |